LENZ Therapeutics announces merger with Graphite Bio to revolutionize presbyopia treatment

In a significant move for the biopharmaceutical industry, LENZ Therapeutics, Inc. (Nasdaq: LENZ), a trailblazer in developing innovative treatments for presbyopia, announced the successful completion ... Read More